Sector
PharmaceuticalsOpen
₹19.11Prev. Close
₹19Turnover(Lac.)
₹0.05Day's High
₹19.11Day's Low
₹18.1652 Week's High
₹27.7452 Week's Low
₹11.5Book Value
₹-14.78Face Value
₹10Mkt Cap (₹ Cr.)
19P/E
0EPS
0Divi. Yield
023 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
6 Sep 2024
12:00 AM
AGM
Announcement Date: 06 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 9.93 | 9.93 | 9.93 | 9.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -23.56 | -22.37 | -20.62 | -17.36 |
Net Worth | -13.63 | -12.44 | -10.69 | -7.43 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 12.25 | 7.84 | 13.57 | 20.45 |
yoy growth (%) | 56.19 | -42.2 | -33.65 | 8.48 |
Raw materials | -8.74 | -4.52 | -6.84 | -10.4 |
As % of sales | 71.34 | 57.67 | 50.4 | 50.84 |
Employee costs | -3.1 | -3.22 | -4.93 | -5.3 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -3.99 | -3.68 | -3.18 | -1.18 |
Depreciation | -0.66 | -0.72 | -0.7 | -0.64 |
Tax paid | -0.96 | 0.83 | 0.67 | 0.41 |
Working capital | -5.79 | 5.62 | -2.44 | -2.57 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 56.19 | -42.2 | -33.65 | 8.48 |
Op profit growth | -19.05 | 12.27 | 2,443.81 | -109.04 |
EBIT growth | -15.71 | 12.46 | 327.74 | -209.11 |
Net profit growth | 74.64 | 13.08 | 227.43 | -2,127.21 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Vimal D Shah
Non Executive Director
Praveen Bafna
Independent Director
Angamuthu Vadivel
Company Sec. & Compli. Officer
Priyanka Lohiya
Additional Director
VENKATACHALAM SATHYA
Plot No 801/P & 802,
GIDC Industrial Estate,
Gujarat - 393002
Tel: 91-2646-223462/227530
Website: http://www.norrispharma.com
Email: norrismedicines@gmail.com; contact@norrispharma.co
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 91-22-23016761/8261
Website: -
Email: -
Summary
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. ...
Read More
Reports by Norris Medicines Ltd
What is the Norris Medicines Ltd share price today?
What is the Market Cap of Norris Medicines Ltd?
What is the PE and PB ratio of Norris Medicines Ltd?
What is the 52 Week High and Low of Norris Medicines Ltd?
What is the CAGR of Norris Medicines Ltd?
What is the shareholding pattern of Norris Medicines Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.